Novartis AG - ADR Financials

$137.48

$0.00 (0.00%)

As on 11-Sep-2026 13:41EDT

Market cap

$309,988 Mln

Revenue (TTM)

$55,635 Mln

P/E Ratio

24.6

P/B Ratio

7.4

Div. Yield

2.9 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	55,634.86	54,811.25	51,722.00	46,660.00	43,461.00	43,974.00
Cost of Revenue	14,220.25	13,689.75	12,827.00	12,472.00	11,582.00	11,735.00
Gross Profit	41,414.61	41,121.51	38,895.00	34,188.00	31,879.00	32,239.00
Operating Expenses	24,422.63	24,047.52	24,351.00	24,419.00	23,933.00	22,183.00
Operating Profit (EBIT)	16,991.98	17,073.99	14,544.00	9,769.00	7,946.00	10,056.00
Other Income	--	--	--	--	--	--
Profit before Tax	15,524.68	16,435.74	13,640.00	9,123.00	7,177.00	24,530.00
Provision for Tax	2,775.63	2,397.21	1,701.00	551.00	1,128.00	1,625.00
Profit after Tax (Net Income)	12,759.05	14,055.61	11,941.00	14,850.00	6,955.00	24,021.00
Minority Interest	10.00	17.00	2.00	-4.00	2.00	3.00
Consolidated Profit	6,337.00	13,984.00	11,941.00	14,850.00	6,955.00	24,021.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	41,542.17	46,130.08	44,046.00	46,667.00	59,342.00	67,655.00
Minority Interest	10.00	--	--	83.00	81.00	167.00
Non-Current Liabilities	48,339.19	41,742.07	29,428.00	26,805.00	29,374.00	33,765.00
Current Liabilities	31,748.13	27,278.05	28,692.00	26,390.00	28,656.00	30,208.00
Total Liabilities	153,781.62	115,569.20	102,246.00	99,945.00	117,453.00	131,795.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	94,682.38	85,109.15	72,542.00	69,464.00	80,543.00	86,077.00
Current Assets	27,351.11	30,460.05	29,704.00	30,481.00	36,910.00	45,718.00
Total Assets	153,781.60	115,569.20	102,246.00	99,945.00	117,453.00	131,795.00
Total Debt*	49,014.20	37,033.06	31,258.00	26,348.00	27,909.00	31,025.00
Net Current Assets	-4,397.00	3,182.00	1,012.00	4,091.00	8,254.00	15,510.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	19,242.03	17,619.00	14,458.00	14,236.00	15,071.00
Cash Flow from Investing Activities	--	-4,901.98	-7,513.00	5,596.00	1,468.00	4,208.00
Cash from Financing Activities	--	-14,943.13	-11,742.00	-14,278.00	-20,562.00	-16,264.00
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	6.63	7.29	5.96	7.19	3.23	10.66
Cash EPS ($)	--	10.05	8.99	11.54	6.57	13.38
Adjusted Book Value ($)	--	23.91	21.98	22.60	27.60	30.03
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	9.98	8.79	7.00	6.62	6.69
Free Cash Flow per Share ($)	--	9.17	6.89	5.67	5.38	5.37

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	17.74	16.10	18.53	7.48	24.88
ROE (%)	29.13	31.17	26.33	28.02	10.95	38.66
ROA (%)	8.80	12.91	11.81	13.66	5.58	18.20
EBIT Margin (%)	30.41	32.17	28.32	21.38	18.35	57.57
Net Margin (%)	22.93	25.64	23.09	31.83	16.00	54.63
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	0.81	0.06	0.11	0.07	-0.01	-0.12
EBIT Growth (%)	1.26	20.41	46.78	25.08	-68.49	135.57
Net Profit Growth (%)	-6.59	17.71	-19.59	113.52	-71.05	197.58
EPS Growth (%)	-3.44	0.22	-0.17	1.22	-0.70	2.01
Book Value Growth (%)	1.32	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	24.64	18.92	16.33	14.04	28.04	8.20
Price / Book Value	7.38	5.77	4.43	4.47	3.29	2.91
Dividend Yield (%)	2.91	--	--	--	--	--
EV/EBITDA	15.55	12.68	10.28	12.10	13.92	6.47
Close Price ($)	156.72	137.87	97.31	100.97	90.72	87.47
High Price ($)	170.46	140.18	120.92	105.61	94.26	98.52
Low Price ($)	112.34	96.91	92.35	79.98	74.09	79.34
Market Cap ($ Cr)	309,987.57	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	0.90	0.80	0.71	0.56	0.47	0.46
Short term debt to equity ratio	0.24	0.13	0.19	0.14	0.10	0.10
Current Ratio	0.86	1.12	1.04	1.16	1.29	1.51
Quick Ratio	0.67	0.89	0.84	0.93	1.04	1.29
Interest Coverage	12.17	14.86	14.13	11.39	9.56	27.97

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	17.71	19.95	15.88	20.09	22.77	21.88
Asset Turnover	0.38	0.50	0.51	0.43	0.35	0.33
Receivable days	--	63.79	62.10	75.42	82.00	77.64
Inventory Days	--	159.98	165.67	191.64	218.24	214.71
Payable days	--	120.44	135.23	147.48	168.70	170.50
Cash Conversion Cycle	--	103.33	92.54	119.58	131.55	121.85

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)